1. Home
  2. INM vs FAMI Comparison

INM vs FAMI Comparison

Compare INM & FAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • FAMI
  • Stock Information
  • Founded
  • INM 1981
  • FAMI 2015
  • Country
  • INM Canada
  • FAMI China
  • Employees
  • INM N/A
  • FAMI N/A
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • FAMI Packaged Foods
  • Sector
  • INM Health Care
  • FAMI Consumer Staples
  • Exchange
  • INM Nasdaq
  • FAMI Nasdaq
  • Market Cap
  • INM 3.2M
  • FAMI 2.1M
  • IPO Year
  • INM N/A
  • FAMI 2018
  • Fundamental
  • Price
  • INM $2.30
  • FAMI $1.67
  • Analyst Decision
  • INM
  • FAMI
  • Analyst Count
  • INM 0
  • FAMI 0
  • Target Price
  • INM N/A
  • FAMI N/A
  • AVG Volume (30 Days)
  • INM 46.6K
  • FAMI 91.6K
  • Earning Date
  • INM 05-13-2025
  • FAMI 05-20-2025
  • Dividend Yield
  • INM N/A
  • FAMI N/A
  • EPS Growth
  • INM N/A
  • FAMI N/A
  • EPS
  • INM N/A
  • FAMI N/A
  • Revenue
  • INM $4,832,013.00
  • FAMI $64,131,332.00
  • Revenue This Year
  • INM N/A
  • FAMI N/A
  • Revenue Next Year
  • INM N/A
  • FAMI N/A
  • P/E Ratio
  • INM N/A
  • FAMI N/A
  • Revenue Growth
  • INM N/A
  • FAMI N/A
  • 52 Week Low
  • INM $1.72
  • FAMI $1.43
  • 52 Week High
  • INM $15.70
  • FAMI $11.28
  • Technical
  • Relative Strength Index (RSI)
  • INM 34.09
  • FAMI 44.39
  • Support Level
  • INM $2.70
  • FAMI $1.60
  • Resistance Level
  • INM $3.20
  • FAMI $1.83
  • Average True Range (ATR)
  • INM 0.23
  • FAMI 0.14
  • MACD
  • INM -0.05
  • FAMI 0.02
  • Stochastic Oscillator
  • INM 5.26
  • FAMI 27.91

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

Share on Social Networks: